Literature DB >> 19532060

HIV molecular epidemiology: transmission and adaptation to human populations.

Zenda Woodman1, Carolyn Williamson.   

Abstract

PURPOSE OF REVIEW: To provide an update on the origin of the HIV epidemic and insights into how the immune response is shaping virus evolution. RECENT
FINDINGS: Characterization of archival samples showed that by the 1960s, HIV had already diverged within humans. It is now estimated that HIV has been in humans since at least the early 1900s. However, despite the potential for different divergent viruses to spread, surprisingly few viruses successfully expanded to cause the global epidemic. In approximately 80% of cases, productive infection is the result of infection with only a single virus or single virus-infected cell. After transmission, HIV evolves at a rapid rate driven by the immune pressure until the virus reaches a delicate survival balance: on one hand avoiding elimination through the development of cytotoxic T-cell immune escape mutations, and on the other sacrificing replication fitness as these mutations may come with a severe fitness cost to the virus. People infected with these 'attenuated' cytotoxic T-cell escape viruses can have a survival advantage. Cytotoxic T-cell responses are molding HIV diversity at a population level resulting in a loss of some of the common immune epitopes.
SUMMARY: Insights into the origin of HIV and its evolution between populations and within individuals is essential to understanding HIV pathogenesis and imperative for the design of effective biomedical interventions such as vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19532060      PMCID: PMC3351078          DOI: 10.1097/COH.0b013e32832c0672

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  41 in total

1.  HIV-1 genomic RNA diversification following sexual and parenteral virus transmission.

Authors:  T F Wolfs; G Zwart; M Bakker; J Goudsmit
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

2.  Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers.

Authors:  Jandre Grobler; Clive M Gray; Cecilia Rademeyer; Cathal Seoighe; Gita Ramjee; Salim Abdool Karim; Lynn Morris; Carolyn Williamson
Journal:  J Infect Dis       Date:  2004-08-25       Impact factor: 5.226

3.  An African HIV-1 sequence from 1959 and implications for the origin of the epidemic.

Authors:  T Zhu; B T Korber; A J Nahmias; E Hooper; P M Sharp; D D Ho
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

4.  Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.

Authors:  Kevin K Ariën; Ryan M Troyer; Youssef Gali; Robert L Colebunders; Eric J Arts; Guido Vanham
Journal:  AIDS       Date:  2005-10-14       Impact factor: 4.177

5.  Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses.

Authors:  D K Clarke; E A Duarte; A Moya; S F Elena; E Domingo; J Holland
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.

Authors:  S M Wolinsky; C M Wike; B T Korber; C Hutto; W P Parks; L L Rosenblum; K J Kunstman; M R Furtado; J L Muñoz
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

7.  Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1.

Authors:  Kimberly Ritola; Christopher D Pilcher; Susan A Fiscus; Noah G Hoffman; Julie A E Nelson; Kathryn M Kitrinos; Charles B Hicks; Joseph J Eron; Ronald Swanstrom
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population.

Authors:  Manish Sagar; Ludo Lavreys; Jared M Baeten; Barbra A Richardson; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Joan K Kreiss; Julie Overbaugh
Journal:  AIDS       Date:  2004-03-05       Impact factor: 4.177

9.  Dual HIV-1 infection associated with rapid disease progression.

Authors:  Geoffrey S Gottlieb; David C Nickle; Mark A Jensen; Kim G Wong; Jandre Grobler; Fusheng Li; Shan-Lu Liu; Cecilia Rademeyer; Gerald H Learn; Salim S Abdool Karim; Carolyn Williamson; Lawrence Corey; Joseph B Margolick; James I Mullins
Journal:  Lancet       Date:  2004-02-21       Impact factor: 79.321

10.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

Authors:  Brandon F Keele; Hui Li; Gerald H Learn; Peter Hraber; Elena E Giorgi; Truman Grayson; Chuanxi Sun; Yalu Chen; Wendy W Yeh; Norman L Letvin; John R Mascola; Gary J Nabel; Barton F Haynes; Tanmoy Bhattacharya; Alan S Perelson; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more
  12 in total

1.  The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.

Authors: 
Journal:  Nat Med       Date:  2010-09       Impact factor: 53.440

2.  Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses.

Authors:  Rajesh Abraham Jacob; Fatima Abrahams; Marcel Tongo; Michael Schomaker; Paul Roux; Eitel Mpoudi Ngole; Wendy A Burgers; Jeffrey R Dorfman
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

Review 3.  Cytopathic bovine viral diarrhea viruses (BVDV): emerging pestiviruses doomed to extinction.

Authors:  Ernst Peterhans; Claudia Bachofen; Hanspeter Stalder; Matthias Schweizer
Journal:  Vet Res       Date:  2010-03-04       Impact factor: 3.683

Review 4.  Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.

Authors:  Diarmaid Hughes; Dan I Andersson
Journal:  Nat Rev Genet       Date:  2015-07-07       Impact factor: 53.242

5.  Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Authors:  Glenda E Gray; Mary Allen; Zoe Moodie; Gavin Churchyard; Linda-Gail Bekker; Maphoshane Nchabeleng; Koleka Mlisana; Barbara Metch; Guy de Bruyn; Mary H Latka; Surita Roux; Matsontso Mathebula; Nivashnee Naicker; Constance Ducar; Donald K Carter; Adrien Puren; Niles Eaton; M Julie McElrath; Michael Robertson; Lawrence Corey; James G Kublin
Journal:  Lancet Infect Dis       Date:  2011-05-11       Impact factor: 25.071

6.  Two Independent HIV Epidemics in Saint Petersburg, Russia Revealed by Molecular Epidemiology.

Authors:  Elena Dukhovlinova; Alexey Masharsky; Olga Toussova; Sergei Verevochkin; Tatiana Solovyeva; Maria Meringof; Elijah Paintsil; Edward White; Russell Barbour; Robert Heimer; Andrei Kozlov
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01-05       Impact factor: 2.205

Review 7.  Strategies to inhibit viral protein nuclear import: HIV-1 as a target.

Authors:  Aviad Levin; Abraham Loyter; Michael Bukrinsky
Journal:  Biochim Biophys Acta       Date:  2010-08-16

8.  Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.

Authors:  Hong Na; Shaona Acharjee; Gareth Jones; Pornpun Vivithanaporn; Farshid Noorbakhsh; Nicola McFarlane; Ferdinand Maingat; Klaus Ballanyi; Carlos A Pardo; Eric A Cohen; Christopher Power
Journal:  Retrovirology       Date:  2011-06-06       Impact factor: 4.602

9.  High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.

Authors:  Niamh M Keane; Steven G Roberts; Coral-Ann M Almeida; Tanya Krishnan; Abha Chopra; Emma Demaine; Rebecca Laird; Monika Tschochner; Jonathan M Carlson; Simon Mallal; David Heckerman; Ian James; Mina John
Journal:  Immunol Cell Biol       Date:  2011-05-17       Impact factor: 5.126

10.  One small step for a yeast--microevolution within macrophages renders Candida glabrata hypervirulent due to a single point mutation.

Authors:  Sascha Brunke; Katja Seider; Daniel Fischer; Ilse D Jacobsen; Lydia Kasper; Nadja Jablonowski; Anja Wartenberg; Oliver Bader; Adela Enache-Angoulvant; Martin Schaller; Christophe d'Enfert; Bernhard Hube
Journal:  PLoS Pathog       Date:  2014-10-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.